false 0001839285 0001839285 2024-02-01 2024-02-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) February 1, 2024

 

HEALTHCARE TRIANGLE, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-40903   84-3559776
(State or other jurisdiction   (Commission File Number)   (IRS Employer
of incorporation)       Identification No.)

 

7901 Stoneridge Dr., Suite 220
Pleasanton, CA 94588

(Address of principal executive offices)

 

(925)-270-4812

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.00001 per share   HCTI   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On February 1, 2024, Mr. Lakshmanan Kannappan notified the Board of the Company of his resignation as a member of the Board of the Company, effective immediately. Mr. Kannappan’s decision to resign from the Board is solely for personal reasons and time considerations, and is not as a result of any disagreement with the Company relating to the Company’s operations, policies, or practices, or otherwise. As there are no disagreements as contemplated by Item 5.02(a) of Form 8-K, the Company is disclosing this information pursuant to Item 5.02(b) of Form 8-K.

 

A copy of their resignation letter is filed with this report as Exhibit 99.1 and is incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit Number   Description
99.1   Resignation Letter, dated as of February 1, 2024
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

  

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Healthcare Triangle, Inc.
     
Date: February 1, 2024 By: /s/ Thyagarajan Ramachandran
  Name:  Thyagarajan Ramachandran
  Title: Chief Financial Officer

 

 

2

 

 

Exhibit 99.1

 

 

 

February 1, 2024

 

To

Dave Rosa

Chairman of the Board

Healthcare Triangle, Inc.

7901 Stoneridge Drive, Suite # 220,

Pleasanton CA, USA 94588

 

Dear Dave,

 

I would like to notify you and the rest of the Board that I have decided to step down from the Board of Director position with Healthcare Triangle, Inc. effective February 01st 2024 due to personal time commitments.

 

Thank you for all the support provided by you, the CFO and the Board during my tenure and I enjoyed working with you all. Looking forward to continue our relationship in other professional activities and opportunities.

 

CC: R. Thyagarajan, Chief Financial Officer, HCTI

 

Yours Sincerely,

 

Lakshmanan (Lena) Kannappan

Head of Strategy and Partnerships, HCTI

1609 N. Terracina Dr

Dublin, CA-94568

email: lena@healthcaretriangle.com

phone: 1-408-605-7548

 

 

 

 

7901 Stoneridge Dr, Suite 220 ● Pleasanton, CA 94588

https://www.healthcaretriangle.com/

 

 

 

 

v3.24.0.1
Cover
Feb. 01, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Feb. 01, 2024
Entity File Number 001-40903
Entity Registrant Name HEALTHCARE TRIANGLE, INC.
Entity Central Index Key 0001839285
Entity Tax Identification Number 84-3559776
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 7901 Stoneridge Dr.
Entity Address, Address Line Two Suite 220
Entity Address, City or Town Pleasanton
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94588
City Area Code 925
Local Phone Number 270-4812
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.00001 per share
Trading Symbol HCTI
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Healthcare Triangle (NASDAQ:HCTI)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Healthcare Triangle Charts.
Healthcare Triangle (NASDAQ:HCTI)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Healthcare Triangle Charts.